Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death

被引:244
作者
Khalifah, AP
Hachem, RR
Chakinala, MM
Schechtman, KB
Patterson, GA
Schuster, DP
Mohanakumar, T
Trulock, EP
Walter, MJ
机构
[1] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Div Cardiothorac Surg, St Louis, MO 63110 USA
关键词
lung transplantation; viruses; bronchiolitis obliterans; risk factors; graft rejection;
D O I
10.1164/rccm.200310-1359OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Bronchiolitis obliterans syndrome (BOS) is the major obstacle to long-term survival after lung transplantation, in part because its pathogenesis is poorly understood and treatment options are limited. To identify unique risk factors for BOS and death, we performed a retrospective cohort study on 259 consecutive adult lung transplant recipients over a 5-year period. The demographic and clinical characteristics of this population were analyzed for an association between BOS or death and potential risk factors, including community-acquired respiratory viral (CARV) infections, acute rejection, and cytomegalovirus pneumonitis. Respiratory syncytial virus, parainfluenza, influenza, and adenovirus accounted for 21 CARV infections. Univariate and multivariate time-dependent Cox regression analyses demonstrated that this CARV group was more likely to develop BOS, death, and death from BOS. Furthermore, these trends were more pronounced in patients with evidence of lower respiratory tract-CARV (lower-CARV) infections. Notably, the CARV and lower-CARV infections were risk factors for BOS, death, and death from BOS distinct from the risk attributable to acute rejection. Identification of CARV and lower-CARV infections as BOS and mortality risk factors has important clinical implications and may provide insight into disease pathogenesis and accelerate the development of novel treatment strategies to modify post-CARV BOS.
引用
收藏
页码:181 / 187
页数:7
相关论文
共 43 条
[1]   The role of the CC chemokine, RANTES, in acute lung allograft rejection [J].
Belperio, JA ;
Burdick, MD ;
Keane, MP ;
Xue, YY ;
Lynch, JP ;
Daugherty, BL ;
Kunkel, SL ;
Strieter, RM .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :461-472
[2]   Respiratory viruses and chronic rejection in lung transplant recipients [J].
Billings, JL ;
Hertz, MI ;
Savik, K ;
Wendt, CH .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (05) :559-566
[3]   Adenovirus infection in the lung results in graft failure after lung transplantation [J].
Bridges, ND ;
Spray, TL ;
Collins, MH ;
Bowles, NE ;
Towbin, JA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (04) :617-623
[4]   Transforming growth factor beta (TGF-β) and obliterative bronchiolitis following pulmonary transplantation [J].
El-Gamel, A ;
Sim, E ;
Hasleton, P ;
Hutchinson, J ;
Yonan, N ;
Egan, J ;
Campbell, C ;
Rahman, A ;
Sheldon, S ;
Deiraniya, A ;
Hutchinson, IV .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (09) :828-837
[5]   Bronchiolitis obliterans after human lung transplantation [J].
Estenne, M ;
Hertz, MI .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (04) :440-444
[6]   Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria [J].
Estenne, M ;
Maurer, JR ;
Boehler, A ;
Egan, JJ ;
Frost, A ;
Hertz, M ;
Mallory, GB ;
Snell, GI ;
Yousem, S .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (03) :297-310
[7]   CYTOMEGALOVIRUS-INFECTION AND PNEUMONITIS - IMPACT AFTER ISOLATED LUNG TRANSPLANTATION [J].
ETTINGER, NA ;
BAILEY, TC ;
TRULOCK, EP ;
STORCH, GA ;
ANDERSON, D ;
RAAB, S ;
SPITZNAGEL, EL ;
DRESLER, C ;
COOPER, JD .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04) :1017-1023
[8]  
Faul JL, 2000, TRANSPLANT INT, V13, P79
[9]   Influenza pneumonia in lung transplant recipients - Clinical features and association with bronchiolitis obliterans syndrome [J].
Garantziotis, S ;
Howell, DN ;
McAdams, HP ;
Davis, RD ;
Henshaw, NG ;
Palmer, SM .
CHEST, 2001, 119 (04) :1277-1280
[10]  
Girgis RE, 1996, J HEART LUNG TRANSPL, V15, P1200